Claveau, S.; Nehlig, É.; Garcia-Argote, S.; Feuillastre, S.; Pieters, G.; Girard, H.A.; Arnault, J.-C.; Treussart, F.; Bertrand, J.-R.
Delivery of siRNA to Ewing Sarcoma Tumor Xenografted on Mice, Using Hydrogenated Detonation Nanodiamonds: Treatment Efficacy and Tissue Distribution. Nanomaterials 2020, 10, 553.
https://doi.org/10.3390/nano10030553
AMA Style
Claveau S, Nehlig É, Garcia-Argote S, Feuillastre S, Pieters G, Girard HA, Arnault J-C, Treussart F, Bertrand J-R.
Delivery of siRNA to Ewing Sarcoma Tumor Xenografted on Mice, Using Hydrogenated Detonation Nanodiamonds: Treatment Efficacy and Tissue Distribution. Nanomaterials. 2020; 10(3):553.
https://doi.org/10.3390/nano10030553
Chicago/Turabian Style
Claveau, Sandra, Émilie Nehlig, Sébastien Garcia-Argote, Sophie Feuillastre, Grégory Pieters, Hugues A. Girard, Jean-Charles Arnault, François Treussart, and Jean-Rémi Bertrand.
2020. "Delivery of siRNA to Ewing Sarcoma Tumor Xenografted on Mice, Using Hydrogenated Detonation Nanodiamonds: Treatment Efficacy and Tissue Distribution" Nanomaterials 10, no. 3: 553.
https://doi.org/10.3390/nano10030553
APA Style
Claveau, S., Nehlig, É., Garcia-Argote, S., Feuillastre, S., Pieters, G., Girard, H. A., Arnault, J.-C., Treussart, F., & Bertrand, J.-R.
(2020). Delivery of siRNA to Ewing Sarcoma Tumor Xenografted on Mice, Using Hydrogenated Detonation Nanodiamonds: Treatment Efficacy and Tissue Distribution. Nanomaterials, 10(3), 553.
https://doi.org/10.3390/nano10030553